Displaying drugs 226 - 250 of 407 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Human cord blood hematopoietic progenitor cell | Not Available |  | A set of stem cells derived from umbilical cord blood used for stem cell donation to unrelated recipients. | Allogeneic Cord Blood Hematopoietic Progenitor Cell Therapy |
| Human calcitonin | 3417.9 C151H226N40O45S3 |  | Human calcitonin is indicated for the treatment of Paget's disease in the cases where the use of salmon calcitonin may provoke the generation of high-titer of antibodies. Paget's disease is... | Calcitonin Preparations |
| Human C1-esterase inhibitor | 68000.0 |  | A C1 inhibitor used to prevent angioedema attacks associated with hereditary angioedema. | Drugs Used in Hereditary Angioedema |
| Human botulinum neurotoxin A/B immune globulin | Not Available | | Human-derived IgG antibodies against botulism toxin types A and B used in the treatment of infant botulism. | Human Immunoglobulin G |
| Hepatitis B immune globulin | Not Available | | An injection of immunoglobulin G (IgG) antibodies to prevent the development of chronic Hepatitis B infection. | Specific Immunoglobulins |
| Hemoglobin | Not Annotated | | An iron-containing protein found in all red blood cells (RBCs) for proper binding of oxygen and transport throughout the body, included in blood transfusions in severe hemorrhage. | Blood Proteins / Globins / Hemoglobins |
| Hemin | Not Available | | An iron-containing porphyrin injection used for the relief of recurrent attacks of acute intermittent porphyria (AIP) associated with the menstrual cycle when carbohydrate therapy is not effective. | Heme products |
| Guselkumab | 143.6 C6402H9864N1676O1994S42 | | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Golimumab | 146943.1937 C6530H10068N1752O2026S44 |  | A TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. | Tumor necrosis factor alpha (TNF-alpha) inhibitors |
| Glucarpidase | 83000.0 C3670H5926N10114O1140S12 |  | A carboxypeptidase enzyme used to reduce plasma concentrations of methotrexate in patients with impaired renal function. | Detoxifying Agents for Antineoplastic Treatment |
| Glucagon | 3767.1 C165H249N49O51S1 |  | A form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures. | Glycogenolytic Hormones |
| Glofitamab | 194000.0 | | A bispecific monoclonal antibody directed against CD20 and CD3 which is used for the treatment of relapsed or refractory diffuse large B-cell lymphoma. | Amino Acids, Peptides, and Proteins / Antibodies / Antibodies, Monoclonal / Bispecific Monoclonal Antibodies / Blood Proteins / Globulins / Immunoglobulins / Immunoproteins / Proteins / Serum Globulins |
| Glatiramer | 7000.0 (C5H9NO4•C3H7NO2•C6H14N2O2•C9H11NO3)x•xC2H4O2 | | An immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS). | Adjuvants, Immunologic |
| Gemtuzumab ozogamicin | 151500.0 |  | A monoclonal anti-CD33 antibody used to treat CD33-positive acute myeloid leukemia. | Antibodies, Monoclonal |
| Gastric intrinsic factor | Not Available | | Intrinsic factor is not currently available in any FDA or Health Canada approved products. However, it is currently in the marketed (but unapproved) product Hematogen in combination with cyanocobalamin (synthetic... | Intrinsic Factor / Mucoproteins |
| Galsulfase | 56012.6 C2534H3851N691O719S16 |  | A recombinant human enzyme used as replacement enzyme therapy for the treatment of of adults and children with Mucopolysaccharidosis VI, a rare genetic disorder caused by a deficiency of a lysosomal enzyme. | Enzymes / Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme |
| Galcanezumab | 147000.0 | | A calcitonin-gene related peptide antagonist used to prevent migraines and treat cluster headaches. | Calcitonin Gene-Related Peptide (CGRP) Antagonists / Calcitonin Gene-Related Peptide Receptor Antagonists |
| Fremanezumab | 148000.0 |  | A humanized monoclonal antibody directed against human calcitonin-gene related peptide to prevent migraines. | Calcitonin Gene-Related Peptide (CGRP) Antagonists |
| Follitropin | 22672.9 C975H1513N267O304S26 |  | A form of recombinant human follicle stimulating hormone used to stimulate follicle development in women with primary ovarian hypogonadism and in men with hypogonadotropic hypogonadism. | Follicle Stimulating Hormone / Gonadotropins / Gonadotropins, Pituitary / Hormones / Thyroid Products |
| Filgrastim | 18800.0 C845H1339N223O243S9 |  | A form of recombinant human granulocyte colony stimulating factor used to induce the production of granulocytes and lower infection risk after myelosuppressive therapy. | Colony-Stimulating Factors |
| Fibrinogen human | Not Available | | A hemostatic agent used for the treatment of acute bleeding episodes in patients with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. | Fibrinogen |
| Fecal microbiota | Not Available | | A bacterial suspension manufactured from human fecal matter used to prevent the recurrence of Clostridioides difficile infection. | Miscellaneous Therapeutic Agents |
| Faricimab | 149000.0 C6506H9968N1724O1026S45 | | An IgG1-derived bispecific antibody against VEGF-A and Ang-2 for the treatment of age-related macular degeneration and diabetic macular edema. | Angiogenesis Inhibitors / Antineovascularisation Agents |
| Fanolesomab | Not Annotated | | An anti-SSEA-1 monoclonal antibody used for imaging of the appendix and to diagnose appendicitis. | Lewis X Antigen |
| Factor XIII (human) | Not Available | | A purified form of Factor XIII that is used to prevent and treat surgical bleeding in patients with a Factor XIII deficiency. | Blood Coagulation Factors / Enzyme Precursors / Factor XIIIa, antagonists & inhibitors / Transglutaminases |
Displaying drugs 226 - 250 of 407 in total